By bringing Exact Sciences into the fold, the expectation is that the focus on cancer diagnostics can provide a jolt to the ...

Scientists and advocates for trans rights say the change will make it much harder to understand cancer diagnoses and trends among the trans population.

RFK. Jr., FDA chief Makary in a power struggle; CDC changes webpage language about vaccine-autism link; Top House Dems unveil drug price negotiation plans.

The Trump administration has decided not to pursue the disability cuts that it has been working on all year — and since at least 2019.

Ketamine, approved as a 505 (j) generic, carries the same tightly defined indications as its reference product, a Ketalar Injection. These include use as the sole anesthetic agent for diagnostic and ...

Johnson & Johnson entered into a definitive agreement to acquire Halda Therapeutics OpCo for $3.05 billion in cash. Eli Lilly announced it will pay $40 million upfront and up to $2.56 billion in a ...

Judge says he’ll approve opioid settlement with OxyContin maker Purdue and Sackler family; Merck buys Cidara; ByHeart’s ...

Former TBWA\WorldHealth CEO Robin Shapiro launched consultancy Way Better Partners. AbbVie announced 20 recipients of its ...

Eric Tennant, 58, died of cancer on Sept. 17. His story illustrates how a bureaucratic process called prior authorization can devastate patients and their families.

Mazur, GM of LillyDirect, breaks down the platform’s new partnership with Walmart and its implications for the pharma ...

The healthcare agency turned to Rise & Run president Linda Bennett to lead FCB Health New York ahead of its merger with Omnicom.

Alkermes ups bid for Avadel as Lundbeck looms; Severe flu season could be on the way for U.S.; Can GLP-1s treat Alzheimer’s?